Author

Dan Kibuule

University of Namibia - Cited by 1,977 - Pharmacoepidemiology - Clinical Pharmacology - Drug Utilization Research

Biography

Dan  Kibuule is working as professor in Department of Psychiatry, University of Nairobi, Kenya. Research experience includes various programs, contributions and participation in different countries for diverse fields of Childhood Anxiety, Depression, Mindfullness Based Therapy, Panic Attacks and Suicidal Thoughts.
Title
Cited by
Year
Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future
OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ...Frontiers in pharmacology, 1205, 2020202
176
2020
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries …
B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ...Current medical research and opinion 36 (2), 301-327, 2020202
127
2020
Strategies to improve antimicrobial utilization with a special focus on developing countries
B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ...Life 11 (6), 528, 2021202
106
2021
Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future
B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ...Frontiers in pharmacology 11, 108, 2020202
103
2020
Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries
B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ...Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020202
69
2020
Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus …
IA Sefah, OO Ogunleye, DO Essah, SA Opanga, N Butt, A Wamaitha, ...Frontiers in pharmacology 11, 8106, 2021202
58
2021
Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications
Q Niaz, B Godman, S Campbell, D KibuuleInternational journal of clinical pharmacy 42 (4), 1227-1236, 2020202
50
2020
Impact of COVID-19 pandemic on pharmaceutical systems and supply chain–a phenomenological study
T Tirivangani, B Alpo, D Kibuule, J Gaeseb, BA AdenugaExploratory Research in clinical and social pharmacy 2, 100037, 2021202
46
2021
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future
B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ...Hospital practice 48 (2), 51-67, 2020202
42
2020
Evidence-based public policy making for medicines across countries: findings and implications for the future
B Godman, J Fadare, HY Kwon, CZ Dias, A Kurdi, IP Dias Godoi, ...Journal of comparative effectiveness research 10 (12), 1019-1052, 2021202
36
2021
Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future
A Etando, AA Amu, M Haque, N Schellack, A Kurdi, AA Alrasheedy, ...Healthcare 9 (12), 1722, 2021202
31
2021
Activities in Namibia to limit the prevalence and mortality from COVID-19 including community pharmacy activities and the implications
D Kibuule, L Nambahu, I Sefah, A Kurdi, T Phuong, HY Kwon, B GodmanScholars Academic Journal of Pharmacy 10 (5), 2021202
30
2021
Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future
B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ...Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022202
27
2022
Coronavirus disease 2019 (COVID-19) pandemic across africa: current status of vaccinations and implications for the future
OO Ogunleye, B Godman, JO Fadare, S Mudenda, AO Adeoti, ...Vaccines 10 (9), 1553, 2022202
16
2022
Effective integration of pharmacovigilance systems at public health facilities in resource-limited settings: A qualitative study
BA Adenuga, D Kibuule, KDS Bamitale, TW RennieResearch in Social and Administrative Pharmacy (8), 1111-11, 2020202
16
2020
Effectiveness of antibiotic stewardship programmes in primary health care settings in developing countries
I Brinkmann, D KibuuleResearch in Social and Administrative Pharmacy 16 (9), 1309-1313, 2020202
15
2020
Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia
D Kibuule, P Aiases, N Ruswa, TW Rennie, RK Verbeeck, B Godman, ...ERJ open research 6 (1), 2020202
14
2020
Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia
BA Adenuga, D Kibuule, TW RennieBasic & Clinical Pharmacology & Toxicology 126 (3), 247-253, 2020202
13
2020
Availability and use of long-acting insulin analogues including their biosimilars across Africa; findings and implications
B Godman, T Leong, AR Abubakar, A Kurdi, F Kalemeera, GM Rwegerera, ...Internal Medicine 11 (4), 2021202
12
2021
Ongoing efforts to improve antimicrobial utilization in hospitals among African countries and implications for the future
Z Saleem, B Godman, A Cook, MA Khan, SM Campbell, RA Seaton, ...Antibiotics 11 (), 1824, 2022202
12
2022

Referred From: https://scholar.google.com/citations?user=b6zp8k8AAAAJ&hl=en

Cited by
Citations 1977
h-index 25
i10-index 44
Recommended Journals
Open Access Journals